Outcome | Indicator | Definition |
---|---|---|
Patient-level clinical | Primary: functional improvement | Patients w/ ≥ 1 follow-up w/ score ≤ 10 or ≥ 50% reduction in baseline WHODAS 2.0 |
Secondary: medication adherence | Patients returning for follow-up visit not missing a dose (patient report and pill counts) | |
Secondary: retention in care | Patients attending scheduled follow-up appointments; and attending those appointments on time. | |
Patient-level process and quality | Vitals recorded | Patients with height, weight, and blood pressure recorded |
Facility-level process and quality | New patient diagnosis | # of new MH patients diagnosed |
Treatment initiation | # of new MH patients starting medication | |
Total patient load | # of MH patients with ≥ 1 follow-up visits in last 3 months | |
Implementation outcomes | Acceptability | % of facility staff reporting satisfaction with SAIA-MH and various strategy components |
Adoption | % of trained facility staff engaging in ≥ 1 implementation plan in first 3 months; # of SAIA-MH cycles completed in first 6 months | |
Fidelity | % of teams following 5-step SAIA-MH process | |
Cost | See economic evaluation section | |
Penetration | % of trained facility staff engaging in ≥ 1 implementation plan during 1-year sustainment phase | |
Sustainability | # of SAIA-MH cycles completed during sustainment phase; facility staff intent-to-continue-use; clinical, process, and quality outcome trends during sustainment |